Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab

J Allergy Clin Immunol Pract. 2022 Sep;10(9):2466-2468. doi: 10.1016/j.jaip.2022.05.016. Epub 2022 May 25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Aspirin / adverse effects
  • Asthma, Aspirin-Induced* / drug therapy
  • Asthma, Aspirin-Induced* / epidemiology
  • Child
  • Humans
  • Nasal Polyps* / epidemiology
  • Prevalence
  • Sinusitis*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • dupilumab
  • Aspirin